Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study

Autor: Calabrò, Luana, Morra, Aldo, Giannarelli, Diana, Amato, Giovanni, D'Incecco, Armida, Covre, Alessia, Lewis, Arthur, Rebelatto, Marlon C, Danielli, Riccardo, Altomonte, Maresa, Di Giacomo, Anna Maria, Maio, Michele
Zdroj: In The Lancet Respiratory Medicine June 2018 6(6):451-460
Databáze: ScienceDirect